申请人:Conforma Therapeutics Corporation
公开号:US07544672B2
公开(公告)日:2009-06-09
Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders. Methods of synthesis and use of such compounds are also described and claimed.
本文描述了炔基吡咯并[2,3-d]嘧啶及其相关类似物,证明其作为抑制热休克蛋白90(HSP90)的药物在治疗和预防各种HSP90介导的疾病中具有实用性。还描述和声明了这种化合物的合成和使用方法。